Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
The Oncologist
Published October 3, 2026
Distinct sleep and rest-activity profiles according to adjuvant treatment exposure in women treat...
October 5, 2026
Medspoke
Medspoke
The Oncologist
Published October 3, 2026
00:00
--:--
REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequenci...
October 5, 2026
Share
REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancer.
https://www.medspoke.co/channel_journal?id=785&tap_id=15037
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
The Oncologist
Published October 3, 2026
Re-evaluating the Role of Adjuvant Chemotherapy after Neoadjuvant Therapy in Resected Gastric Can...
October 5, 2026
Why are you reporting this TALK?